Climb Bio Statistics

Total Valuation

Climb Bio has a market cap or net worth of $80.97 million. The enterprise value is -$131.03 million.

Market Cap	80.97M
Enterprise Value	-131.03M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Climb Bio has 67.48 million shares outstanding. The number of shares has increased by 78.47% in one year.

Current Share Class	67.48M
Shares Outstanding	67.48M
Shares Change (YoY)	+78.47%
Shares Change (QoQ)	-3.40%
Owned by Insiders (%)	0.60%
Owned by Institutions (%)	41.28%
Float	30.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.38
P/TBV Ratio	0.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 31.41, with a Debt / Equity ratio of 0.00.

Current Ratio	31.41
Quick Ratio	30.83
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.26% and return on invested capital (ROIC) is -10.54%.

Return on Equity (ROE)	-46.26%
Return on Assets (ROA)	-10.30%
Return on Invested Capital (ROIC)	-10.54%
Return on Capital Employed (ROCE)	-12.72%
Revenue Per Employee	n/a
Profits Per Employee	-$6.72M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.20% in the last 52 weeks. The beta is -0.10, so Climb Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-56.20%
50-Day Moving Average	1.52
200-Day Moving Average	4.34
Relative Strength Index (RSI)	34.56
Average Volume (20 Days)	172,480

Short Selling Information

The latest short interest is 2.19 million, so 3.25% of the outstanding shares have been sold short.

Short Interest	2.19M
Short Previous Month	2.00M
Short % of Shares Out	3.25%
Short % of Float	7.15%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.00M
Pretax Income	n/a
Net Income	-73.90M
EBITDA	n/a
EBIT	-27.00M
Earnings Per Share (EPS)	-$1.53

Full Income Statement

Balance Sheet

The company has $150.92 million in cash and $532,000 in debt, giving a net cash position of $212.00 million or $3.14 per share.

Cash & Cash Equivalents	150.92M
Total Debt	532,000
Net Cash	212.00M
Net Cash Per Share	$3.14
Equity (Book Value)	211.88M
Book Value Per Share	3.15
Working Capital	149.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-15.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Climb Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.47%
Shareholder Yield	-78.47%
Earnings Yield	-91.26%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1